z-logo
Premium
Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in C hina
Author(s) -
Zhang H.,
Yang Y.,
Zhu J.,
Shao X.,
Liu Y.,
Zhao L.,
Yu P.,
Zhang H.,
He Q.,
Gu X.
Publication year - 2014
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12487
Subject(s) - medicine , atrial fibrillation , emergency department , valvular heart disease , heart failure , atrial flutter , cardiology , prospective cohort study , comorbidity , stroke (engine) , concomitant , coronary artery disease , diabetes mellitus , mechanical engineering , psychiatry , engineering , endocrinology
Background/Aim There have been several studies of atrial fibrillation ( AF ) over the past decades; however, data from C hinese patients are scarce. The aim of the study was therefore to describe the patient characteristics, risk profile and management strategies for C hinese AF patients presenting to emergency department ( ED ). Methods We conducted a prospective, multicentre registry of patients with AF or atrial flutter ( AFL ) in C hina. Participants were enrolled at 20 ED s, then data regarding baseline characteristics and treatment in ED s were collected. Results Of the 2016 C hinese patients, 1104 (54.8%) were female. Six hundred eighteen (30.7%) had paroxysmal AF , 452 (22.4%) had persistent AF and 945 (46.9%) had permanent AF . The most common comorbidity was hypertension (55.5%), followed by coronary artery disease (41.8%) and heart failure ( HF , 37.4%). The prevalence of concomitant cardiovascular risk factors, such as HF and valvular heart disease, increased as AF progressed. Among the patients with non‐valvular AF , 110 (12.7%) of those with CHADS 2 (congestive HF , hypertension, age of 75 years and greater, diabetes mellitus and history of stroke) ≥2 were prescribed oral anticoagulants ( OAC ), while 119 (15.6%) of those with CHADS 2 <2 received such agents. Among the 324 patients with valvular AF , 134 (41.4%) actually were treated with OAC . The international normalised ratio value was within the target range (2.0–3.0) in 96 patients only (26.4%). Moreover, a total of 16.2% of the patients received ≥1 anti‐arrhythmic agents, whereas rate control agents were used more frequently (68.4%). Conclusions According to the present study, the risk profile and management of C hinese patients with AF / AFL differed from that observed in previous studies. The use of OAC inadequately deviate from current guidelines.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here